A synthetic non-degradable polyethylene glycol hydrogel retards adverse post-infarct left ventricular remodeling.

Abstract:

BACKGROUND:Left ventricular remodeling after myocardial infarction is a key component of heart failure and it has long been postulated that it may result from increased wall stress. It has recently been suggested that an injectable, non-degradable polymer may limit pathological remodeling in a manner analogous to that of cardiac support devices. We have tested a non-degradable polyethylene glycol (PEG) gel in a rat infarction model. METHODS AND RESULTS:After permanent ligation of the left anterior descending artery in male Wistar rats, PEG gel reagents were injected into the infarcted region and polymerized in situ. At 4 weeks, fractional shortening and infarct volume were unchanged relative to a saline injected control, but the infarct-induced left ventricular end-diastolic diameter (LVEDD) increase was substantially reduced (43%, P < .05) and wall thinning was completely prevented. At 13 weeks, the LVEDD were similar for both saline- and PEG-injected hearts. The non-degradable PEG gels did elicit a macrophage-based inflammatory reaction. CONCLUSIONS:The injection of non-degradable synthetic gel was effective in ameliorating pathological remodeling in the immediate postinfarction healing phase, but was unable to prevent the dilation that occurred at later stages in the healed heart.

journal_name

J Card Fail

authors

Dobner S,Bezuidenhout D,Govender P,Zilla P,Davies N

doi

10.1016/j.cardfail.2009.03.003

subject

Has Abstract

pub_date

2009-09-01 00:00:00

pages

629-36

issue

7

eissn

1071-9164

issn

1532-8414

pii

S1071-9164(09)00096-7

journal_volume

15

pub_type

杂志文章
  • Left Atrial Volume as a Predictor of Left Ventricular Functional Recovery in Patients With Dilated Cardiomyopathy and Absence of Delayed Enhancement in Cardiac Magnetic Resonance.

    abstract:BACKGROUND:Improvement of left ventricular (LV) systolic dysfunction can occur in patients with dilated cardiomyopathy (DCM), and it is more frequently observed if patients have no delayed enhancement (DE) in cardiac magnetic resonance imaging (CMR). However, even in the absence of DE, not all patients have functional ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2015.12.011

    authors: Moon J,Shim CY,Kim YJ,Park S,Kang SM,Chung N,Ha JW

    更新日期:2016-04-01 00:00:00

  • Left ventricular geometry, global function, and dyssynchrony in infants and children with pompe cardiomyopathy undergoing enzyme replacement therapy.

    abstract:BACKGROUND:Enzyme replacement therapy (ERT) for infantile-onset Pompe disease effectively reduces the left ventricular (LV) mass. This study sought to explore detailed process of LV reverse remodeling after ERT with the use of tissue Doppler and stain rate imaging. METHODS AND RESULTS:Nine infants and children with Po...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2011.07.011

    authors: Chen CA,Chien YH,Hwu WL,Lee NC,Wang JK,Chen LR,Lu CW,Lin MT,Chiu SN,Chiu HH,Wu MH

    更新日期:2011-11-01 00:00:00

  • Influence of Donor Transmitted and Rapidly Progressive Coronary Vascular Disease on Long-Term Outcomes After Heart Transplantation: A Contemporary Intravascular Ultrasound Analysis.

    abstract:BACKGROUND:Donor-transmitted atherosclerosis (DTA) and rapidly progressive cardiac allograft vasculopathy (CAV) at 1 year are intravascular ultrasound (IVUS)-derived measures shown to predict adverse cardiovascular outcomes in the setting of early generation immunosuppressive agents. Given the paucity of data on the pr...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2020.12.012

    authors: Sperry BW,Qarajeh R,Omer MA,Brandt H,Safley D,Borkon AM,Everley MP,Fendler TJ,Khumri TM,Lawhorn SL,Magalski A,Nassif ME,Vodnala D,Kao AC,Austin BA

    更新日期:2021-01-20 00:00:00

  • How does cardiac resynchronization therapy improve exercise capacity in chronic heart failure?

    abstract:BACKGROUND:Studies have shown that neither ejection fraction nor hemodynamic abnormalities during exercise in chronic heart failure (HF) correlate with symptoms of fatigue and exhaustion. The concept that exercise limitation in patients with chronic HF is due to abnormal hemodynamics during exercise has been revised to...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1016/j.cardfail.2005.03.002

    authors: Middlekauff HR

    更新日期:2005-09-01 00:00:00

  • Multiple neurohumoral modulating agents in systolic dysfunction heart failure: are we lowering blood pressure too much?

    abstract:BACKGROUND:Disease-modifying drug treatment in heart failure (HF) reduces blood pressure. Titration of these agents is guided by clinic blood pressure readings; however, the impact of such treatment on blood pressure is unknown because diurnal blood pressure patterns remain poorly described. The aim of this study was t...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2008.03.003

    authors: Mak G,Murphy NF,Ali A,Walsh A,O'Loughlin C,Conlon C,McCaffrey D,Ledwidge M,McDonald K

    更新日期:2008-09-01 00:00:00

  • Dual Vasopressin V1a/V2 Antagonism: The Next Step in Neurohormonal Modulation in Patients With Heart Failure?

    abstract::Stimulation of the V1a receptor for arginine vasopressin produces myocardial and vascular effects similar to those of angiotensin II while stimulation of the V2 receptor causes fluid retention. There are no data with sustained blockade of the V1a receptor while single-dose experiments suggest benefit. Acute and chroni...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1016/j.cardfail.2017.12.011

    authors: Goldsmith SR,Udelson JE,Gheorghiade M

    更新日期:2018-02-01 00:00:00

  • Sensitivity and Specificity of a Five-Minute Cognitive Screening Test in Patients With Heart Failure.

    abstract:BACKGROUND:Cognitive impairment occurs in up to 80% of patients with heart failure (HF). The National Institute for Neurological Disorders and Stroke (NINDS) and the Canadian Stroke Network (CSN) recommend a 5-minute cognitive screening protocol that has yet to be psychometrically evaluated in HF populations. The aim o...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2015.08.343

    authors: Cameron JD,Gallagher R,Pressler SJ,McLennan SN,Ski CF,Tofler G,Thompson DR

    更新日期:2016-02-01 00:00:00

  • Can Biomarkers Provide Right Ventricular-Specific Prognostication in the Perioperative Setting?

    abstract::Since the introduction of biomarkers in the late 1980s, considerable research has been dedicated to their validation and application. As a result, many biomarkers are now commonly used in clinical practice. However, the role of biomarkers in the prediction of right ventricular failure (RVF) and in the prognostication ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2019.09.007

    authors: Jabagi H,Ruel M,Sun LY

    更新日期:2020-09-01 00:00:00

  • Effects of High-Intensity Interval Exercise Training on Skeletal Myopathy of Chronic Heart Failure.

    abstract:BACKGROUND:It remains controversial which type of exercise elicits optimum adaptations on skeletal myopathy of heart failure (HF). Our aim was to evaluate the effect of high-intensity interval training (HIIT), with or without the addition of strength training, on skeletal muscle of HF patients. METHODS AND RESULTS:Thi...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2016.06.007

    authors: Tzanis G,Philippou A,Karatzanos E,Dimopoulos S,Kaldara E,Nana E,Pitsolis T,Rontogianni D,Koutsilieris M,Nanas S

    更新日期:2017-01-01 00:00:00

  • Outcomes of volume-overloaded cardiovascular patients treated with ultrafiltration.

    abstract:BACKGROUND:Ultrafiltration (UF) can rapidly and predictably remove extracellular and intravascular fluid volume. To date, assessment of UF in patients with cardiovascular disease has been confined to short- and medium-term studies in patients with a principal diagnosis of acute heart failure. METHODS:In-hospital and l...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2008.02.003

    authors: Jaski BE,Romeo A,Ortiz B,Hoagland PM,Stone M,Glaser D,Thomas L,Walsh C,Smith SC Jr

    更新日期:2008-08-01 00:00:00

  • Effects of different degrees of sympathetic antagonism on cytokine network in patients with ischemic dilated cardiomyopathy.

    abstract:BACKGROUND:The proinflammatory cytokines have been implicated in the pathogenesis of heart failure. Recent studies have shown that beta-adrenergic blockade can modulate cytokine production. This study investigates the different impact of different degrees of sympathetic antagonism on circulating levels of cytokines in ...

    journal_title:Journal of cardiac failure

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2004.07.006

    authors: Cinquegrana G,D'Aniello L,Landi M,Spinelli L,Grande G,De Prisco F,Petretta M

    更新日期:2005-04-01 00:00:00

  • Pharmacotherapy Use in Older Patients With Heart Failure and Reduced Ejection Fraction After a Skilled Nursing Facility Stay.

    abstract:BACKGROUND:Little is known about guideline-directed pharmacotherapy use in patients with heart failure and reduced ejection fraction (HFrEF) discharged to skilled nursing facilities (SNFs). This study aimed to describe the use of angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blocker (ARBs) and e...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2017.09.007

    authors: Li L,Jesdale BM,Hume A,Gambassi G,Goldberg RJ,Lapane KL

    更新日期:2017-12-01 00:00:00

  • The impact of heart failure on the classification of COPD severity.

    abstract:BACKGROUND:Pulmonary restriction-a reduction of lung volumes-is common in heart failure (HF), rendering severity grading of chronic obstructive pulmonary disease (COPD) potentially problematic in subjects with both diseases. We compared pulmonary function in patients with either HF or COPD, or the combination to assess...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2012.05.008

    authors: Güder G,Rutten FH,Brenner S,Angermann CE,Berliner D,Ertl G,Jany B,Lammers JW,Hoes AW,Störk S

    更新日期:2012-08-01 00:00:00

  • Plasma corin levels provide minimal prognostic utility incremental to natriuretic peptides in chronic systolic heart failure.

    abstract:BACKGROUND:Corin is a serine protease that cleaves pro-atrial and pro-B-type natriuretic peptides into biologically active hormones. The relationship between soluble plasma corin levels, plasma natriuretic peptide levels, myocardial structure and performance, and long-term clinical outcomes in the setting of chronic sy...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2010.03.010

    authors: Shrestha K,Troughton RW,Borowski AG,Yandle TG,Richards AM,Klein AL,Tang WH

    更新日期:2010-08-01 00:00:00

  • Noninvasive monitoring of left ventricular end-diastolic pressure reduces rehospitalization rates in patients hospitalized for heart failure: a randomized controlled trial.

    abstract:BACKGROUND:In patients admitted for heart failure (HF), unrecognized elevation of left ventricular end-diastolic pressure (LVEDP) at the time of discharge may have a role in the high rehospitalization rate for HF on follow-up. METHODS AND RESULTS:In a small, prospective study (n = 50), patients admitted for HF were ra...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2011.04.014

    authors: Sharma GV,Woods PA,Lindsey N,O'Connell C,Connolly L,Joseph J,McIntyre KM

    更新日期:2011-09-01 00:00:00

  • Identification of Heart Failure Events in Medicare Claims: The Atherosclerosis Risk in Communities (ARIC) Study.

    abstract:BACKGROUND:We examined the accuracy of Medicare heart failure (HF) diagnostic codes in the identification of acute decompensated (ADHF and chronic stable (CSHF) HF. METHODS AND RESULTS:Hospitalizations were identified from medical discharge records for Atherosclerosis Risk in Communities (ARIC) study participants with...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2015.07.013

    authors: Kucharska-Newton AM,Heiss G,Ni H,Stearns SC,Puccinelli-Ortega N,Wruck LM,Chambless L

    更新日期:2016-01-01 00:00:00

  • Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction.

    abstract::The aim of this study was to compare the effects on left ventricular function and exercise tolerance of a selective beta-antagonist (atenolol) with those of another selective beta 1-antagonist with vasodilator properties (nebivolol) in patients with ischemic left ventricular dysfunction but no overt congestive heart f...

    journal_title:Journal of cardiac failure

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s1071-9164(96)80004-2

    authors: Rousseau MF,Chapelle F,Van Eyll C,Stoleru L,Hager D,Van Nueten L,Pouleur H

    更新日期:1996-03-01 00:00:00

  • Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure.

    abstract:BACKGROUND:Insulin resistance is present in the setting of congestive heart failure. Glucagon-like peptide-1 (GLP-1) is a naturally occurring incretin with both insulinotropic and insulinomimetic properties. METHODS AND RESULTS:We investigated the safety and efficacy of a 5-week infusion of GLP-1 (2.5 pmol/kg/min) add...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2006.08.211

    authors: Sokos GG,Nikolaidis LA,Mankad S,Elahi D,Shannon RP

    更新日期:2006-12-01 00:00:00

  • Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial.

    abstract:BACKGROUND:In patients with heart failure and preserved ejection fraction (HF-PEF) randomized in the Americas as part of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, treatment with spironolactone enhanced the risk of hyperkalemia but reduced the risk of hypoka...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.cardfail.2018.03.002

    authors: Desai AS,Liu J,Pfeffer MA,Claggett B,Fleg J,Lewis EF,McKinlay S,O'Meara E,Shah SJ,Sweitzer NK,Solomon S,Pitt B

    更新日期:2018-05-01 00:00:00

  • Muscle cell grafting for the treatment and prevention of heart failure.

    abstract:BACKGROUND:The review aims to highlight recent advances in cardiac and skeletal muscle cell grafting for myocardial infarct repair. RESULTS:Fetal and neonatal cardiomyocytes form new myocardium in normal or injured hearts, and this new myocardium differentiates toward an adult phenotype. Unfortunately, formation of ne...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1054/jcaf.2002.129268

    authors: Murry CE,Whitney ML,Reinecke H

    更新日期:2002-12-01 00:00:00

  • Did Frédéric Chopin Die From Heart Failure?

    abstract::On October 17, 1849, Poland's greatest composer, Frédéric Chopin (1810-1849) died aged 39. His cause of death remains unknown. An investigation of the documental sources was performed to reconstruct the medical history of the artist. Since his earliest years, his life had been dominated by poor health. Recurrent episo...

    journal_title:Journal of cardiac failure

    pub_type: 传,历史文章

    doi:10.1016/j.cardfail.2018.03.009

    authors: Perciaccante A,Charlier P,Negri C,Coralli A,Appenzeller O,Bianucci R

    更新日期:2018-05-01 00:00:00

  • Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.

    abstract:BACKGROUND:Heart failure in blacks has been associated with a poorer prognosis than in whites. In such diseases as hypertension, blacks show pathophysiological differences and respond differently to some therapies than whites. The aim of this study is to evaluate the clinical characteristics and response to therapy of ...

    journal_title:Journal of cardiac failure

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s1071-9164(99)90001-5

    authors: Carson P,Ziesche S,Johnson G,Cohn JN

    更新日期:1999-09-01 00:00:00

  • Risk Prediction Models for Incident Heart Failure: A Systematic Review of Methodology and Model Performance.

    abstract:BACKGROUND:Numerous models predicting the risk of incident heart failure (HF) have been developed; however, evidence of their methodological rigor and reporting remains unclear. This study critically appraises the methods underpinning incident HF risk prediction models. METHODS AND RESULTS:EMBASE and PubMed were searc...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1016/j.cardfail.2017.03.005

    authors: Sahle BW,Owen AJ,Chin KL,Reid CM

    更新日期:2017-09-01 00:00:00

  • Brief Report: Patient Activation Among Urban Hospitalized Patients With Heart Failure.

    abstract:BACKGROUND:Patient activation influences patients' ability to meaningfully engage in critical heart failure self-care. The purpose of this study was to identify whether patient activation is associated with patient-reported health outcomes in an urban and racially diverse inpatient sample of patients with heart failure...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2017.08.452

    authors: Masterson Creber R,Chen T,Wei C,Lee CS

    更新日期:2017-11-01 00:00:00

  • Peak oxygen consumption and outcome in heart failure patients chronically treated with beta-blockers.

    abstract:BACKGROUND:Peak oxygen consumption (VO(2)) is an important criterion for listing patients for cardiac transplantation. Beta-blockers improve survival without affecting peak VO(2). We questioned the value of peak VO(2) in predicting outcome in patients treated with beta-blockers. METHODS AND RESULTS:We reviewed the rec...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/s1071-9164(03)00593-1

    authors: Shakar SF,Lowes BD,Lindenfeld J,Zolty R,Simon M,Robertson AD,Bristow MR,Wolfel EE

    更新日期:2004-02-01 00:00:00

  • The extracellular connections: the role of integrins in myocardial remodeling.

    abstract:BACKGROUND:Integrins are a large family of heterodimeric cell surface receptors that are present on all cells. These molecules link the extracellular matrix to the intracellular cytoskeleton and are multifunctional, playing roles in cell organization and differentiation, migration, alteration of gene expression, and ce...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1054/jcaf.2002.129263

    authors: Ross RS

    更新日期:2002-12-01 00:00:00

  • Pulmonary hypertension and systemic hypotension as limitations to exercise in chronic heart failure.

    abstract::The authors have previously shown that the resistance ratio (RR) is increased in patients with congestive heart failure (CHF), and that the patients with the highest RRs have an increased mortality. The authors hypothesized that CHF patients with the lowest maximum oxygen consumption and the most impaired Weber functi...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/1071-9164(94)90005-1

    authors: Mabee SW,Metra M,Reed DE,Dei Cas L,Cody RJ

    更新日期:1994-10-01 00:00:00

  • Tolerability to beta-blocker therapy among heart failure patients in clinical practice.

    abstract:BACKGROUND:Although beta-blockers were well-tolerated by heart failure (HF) patients in clinical trials, tolerability of these drugs in a general population of HF patients is not well-described. METHODS:We studied a total of 308 encounters with beta-blockers therapy in 268 ambulatory HF patients. Side effects and freq...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究

    doi:10.1054/jcaf.2003.34

    authors: Butler J,Khadim G,Belue R,Chomsky D,Dittus RS,Griffin M,Wilson JR

    更新日期:2003-06-01 00:00:00

  • Effects of Angiotensin-Neprilysin Inhibition in Canines with Experimentally Induced Cardiorenal Syndrome.

    abstract:BACKGROUND:Sacubitril/valsartan (Sac/Val), a combined angiotensin-II receptor blocker (Val) and neprilysin inhibitor (Sac) in a 1:1 molar ratio, was shown to decrease the risk of cardiovascular death or heart failure (HF) hospitalization in patients with HF and reduced left ventricular (LV) ejection fraction. This stud...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2020.08.009

    authors: Sabbah HN,Zhang K,Gupta RC,Xu J,Singh-Gupta V

    更新日期:2020-11-01 00:00:00

  • The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD Registry.

    abstract:BACKGROUND:Myocarditis complicated by cardiogenic shock remains a complex problem. The use of acute mechanical circulatory support devices for cardiogenic shock is growing. We explored the utility of Impella transvalvular microaxial flow catheters in the setting of myocarditis with cardiogenic shock. METHODS AND RESUL...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.cardfail.2018.09.007

    authors: Annamalai SK,Esposito ML,Jorde L,Schreiber T,A Hall S,O'Neill WW,Kapur NK

    更新日期:2018-10-01 00:00:00